7.90 USD
▲+0.41+5.76%
盘后 7.13 -4.55%
2026-08-03
市值
$71.95M
市盈率
—
EPS
-16.06
股息率
—
52 周区间
3.53 – 14.21
成交量
4.14K
Beta
2.02
目标价
18.00
52W 低 3.5352W 高 14.21
价格走势
公司简介
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company’s lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clini...